Technology ID
TT-0117
Description
Next-generation CRISPR-enhanced microfluidic system for at-home nucleic acid-based disease screening.
Content
CRISPR-Enhanced Precision: Patented diagnostic technology with new Cas12 RNA cleavage improves the specificity of isothermal nucleic acid tests, delivering PCR-level performance
Multi-Disease Detection: Capable of simultaneously targeting up to 5 diseases using a disposable plastic cartridge with a reusable reader
Rapid and Efficient: Provides a sample-in to answer-out solution within 35 minutes
3 US Patent filed, several others under preparation
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL
Images
